Informa has acquired Dove Medical Press to strengthening its capability and presence in the OA (open access) publishing market. Terms were not disclosed.
In a press release Informa said that Dove Medical Press is an independent OA journals publisher, founded in 2003, producing a range of quality OA journals, mainly in Health Sciences, with additional content in Science and Technology. A large proportion of its journals are indexed by the Web of Science and PubMed and a growing number have established and improving impact factors. Leading titles include OncoTargets and Therapy, International Journal of Nanomedicine and Clinical Ophthalmology.
The addition of Dove Medical Press complements our growing portfolio of OA titles published under the Taylor & Francis and Cogent brands, enabling continued expansion in the attractive OA market. Following the acquisition, Informa will publish more than 200 OA journals, as part of a total journal portfolio of more than 2,500 titles, providing a valuable and growing alternative publishing outlet for authors.
Financial details were not disclosed but the transaction is expected to be modestly accretive to adjusted earnings in the first full year of ownership and deliver a return on investment ahead of the cost of capital within three years.
Informa Group PLC
Informa is a leading international Business Intelligence, Exhibitions, Events and Academic Publishing Group with annual revenues of over £1.6bn. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn.
Dove Medical Press Ltd
Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Dove Press was founded in 2003 with the objective of combining the highest editorial standards with the ‘best of breed’ new publishing technologies. Dove Press has offices in Manchester and London in the United Kingdom, representatives in Princeton, New Jersey in the United States, and editorial offices in Auckland, New Zealand.